期刊文献+

低分子肝素治疗急性脑梗死的临床研究 被引量:3

A study on the treatment of acute cerebral infarction with low molecular weight heparin
下载PDF
导出
摘要 目的观察低分子肝素 (LMWH)治疗急性脑梗死的疗效及安全性。方法将 10 6例起病在 48小时内的急性脑梗死患者随机分为治疗组和对照组 ,分别给予低分子肝素及普通治疗。结果治疗组较对照组神经功能明显提高 (P <0 0 1) ,治疗期间无不良反应及并发症。结论低分子肝素治疗急性脑梗死是安全有效的。 Objective To study the effect and the safety of low molecular weight heparin (LMWH) on the treatment of acute cerebral infarction. Methods 106 cases with cerebral infarction within 48 hours of onset were randomly divided into LMWH treated group and control group. Results Neurological improvement was significantly higher in the LMWH treated group than in the control group ( P <0.01). There were no side-effects and complications during treatment. Conclusion The treatment of acute cerebral infarction with low molecular weight heparin is satisfaction.
出处 《贵州医药》 CAS 2001年第5期420-421,共2页 Guizhou Medical Journal
关键词 低分子肝素 急性脑梗死 神经功能 治疗 临床研究 疗效 Low molecular weight heparin Acute cerebral infarction Neurological function
  • 相关文献

参考文献4

二级参考文献8

共引文献273

同被引文献12

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部